Interested in learning more? Please send us a message using our contact form.
Barriers to cervical cancer screening in low resource settings include lack of accessible high quality services, high cost, and the need for multiple visits...Read Full Article >>
Papanicolaou smear-based cervical cancer screening programs have been successful in the developed world to reduce the burden of cervical cancer ...Read Full Article >>
Our goal was to develop a tele-colposcopy platform for primary-care clinics to improve screening sensitivity and access...Read Full Article >>
We have previously developed a portable Pocket Colposcope for cervical cancer screening in resource-limited settings...Read Full Article >>
Current guidelines by WHO for cervical cancer screening in low- and middle-income countries involves visual inspection with acetic acid (VIA) of the cervix, followed by treatment during the same visit or a subsequent visit with cryotherapy if a suspicious lesion is found...Read Full Article >>
Invasive cervical cancer is preventable, yet affects 500,000 women worldwide each year, and over half these women die...Read Full Article >>
In this paper, we propose methods for (1) automatic feature extraction and classification for acetic acid and Lugol's iodine cervigrams and (2) methods for combining features/diagnosis of different contrasts in cervigrams for improved performance...Read Full Article >>
Numerous countries have taken part in our clinical investigations and benefited from improved access to women’s healthcare options.
We have expanded to 8 sites around the world and continue to grow our reach with powerful women’s health innovations.
We have enrolled a staggering amount of patients, providing necessary access to healthcare technology previously outside the reach of these countries.
We've conducted clinical investigations in over 8 countries across 4 continents. Our latest product launch, The Pocket Colposcope, received FDA clearance in September 2018.